Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

The US Food and Drug Administration recently convened a panel of experts to examine a sensitive and increasingly urgent ...

A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted to ...

As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school ...

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...

Experts warn that downplaying risks of untreated maternal depression could endanger pregnant individuals and their babies. Last Monday, an expert panel convened by the U.S. Food and Drug ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts said antidepressants were safe and necessary.

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...